MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
This Quarter Return
+5.11%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$243M
AUM Growth
+$243M
(+26%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
16.82%
Top 10 Holdings %
Top 10 Hldgs %
38.35%
Holding
83
New
7
Increased
49
Reduced
17
Closed
4
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$1.92M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$1.71M |
| 3 |
Procter & Gamble
PG
|
$1.69M |
| 4 |
Chubb
CB
|
$1.63M |
| 5 |
Intel
INTC
|
$1.57M |
Top Sells
| 1 |
J.M. Smucker
SJM
|
$957K |
| 2 |
Schlumberger
SLB
|
$503K |
| 3 |
Honeywell
HON
|
$272K |
| 4 |
UFP Industries
UFPI
|
$236K |
| 5 |
ANSS
Ansys
ANSS
|
$215K |
Sector Composition
| 1 | Healthcare | 22.45% |
| 2 | Technology | 21.69% |
| 3 | Industrials | 15.7% |
| 4 | Financials | 9.77% |
| 5 | Consumer Staples | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$635B
| $3.38M | 1.39% |
71,526
+19,076
| +36% | +$902K |
|
27
Chevron
CVX
$324B
| $2.9M | 1.19% |
23,122
+316
| +1% | +$39.6K |
|
28
Xylem
XYL
$34.5B
| $2.85M | 1.17% |
41,770
+12,375
| +42% | +$844K |
|
29
PepsiCo
PEP
$204B
| $2.73M | 1.13% |
22,786
-100
| -0.4% | -$12K |
|
30
EOG Resources
EOG
$68.2B
| $2.33M | 0.96% |
21,575
+12,120
| +128% | +$1.31M |
|
31
AbbVie
ABBV
$372B
| $1.85M | 0.76% |
19,126
+1,900
| +11% | +$184K |
|
32
Illumina
ILMN
$15.8B
| $1.8M | 0.74% |
8,240
+2,225
| +37% | +$486K |
|
33
Empire State Realty Series ES
ESBA
$2.04B
| $1.79M | 0.74% |
86,573
+2,000
| +2% | +$41.4K |
|
34
Merck
MRK
$210B
| $1.76M | 0.72% |
31,202
+2,770
| +10% | +$156K |
|
|
35
J.M. Smucker
SJM
$11.8B
| $1.5M | 0.62% |
12,087
-7,710
| -39% | -$957K |
|
36
GE Aerospace
GE
$292B
| $1.5M | 0.62% |
85,735
+15,011
| +21% | +$262K |
|
37
Emerson Electric
EMR
$74.3B
| $1.44M | 0.6% |
20,726
-358
| -2% | -$24.9K |
|
38
Visa
V
$683B
| $1.29M | 0.53% |
11,280
+960
| +9% | +$110K |
|
39
Gilead Sciences
GILD
$140B
| $1.28M | 0.53% |
17,896
+2,050
| +13% | +$147K |
|
40
McCormick & Company Non-Voting
MKC
$18.9B
| $1.18M | 0.49% |
11,625
+2,650
| +30% | +$270K |
|
41
Bristol-Myers Squibb
BMY
$96B
| $1.11M | 0.46% |
18,100
+6,900
| +62% | +$423K |
|
|
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.11M | 0.46% |
16,600
+3,800
| +30% | +$253K |
|
|
43
Schlumberger
SLB
$55B
| $1.1M | 0.45% |
16,323
-7,469
| -31% | -$503K |
|
44
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.04M | 0.43% |
5,250
-200
| -4% | -$39.7K |
|
45
Vanguard Total Stock Market ETF
VTI
$526B
| $961K | 0.4% |
7,000
-1,000
| -13% | -$137K |
|
46
Fortive
FTV
$16.2B
| $943K | 0.39% |
13,020
+575
| +5% | +$41.6K |
|
47
Colgate-Palmolive
CL
$67.9B
| $842K | 0.35% |
11,157
+2,950
| +36% | +$223K |
|
48
Union Pacific
UNP
$133B
| $791K | 0.33% |
5,900
-300
| -5% | -$40.2K |
|
49
State Street
STT
$32.6B
| $743K | 0.31% |
7,599
+550
| +8% | +$53.8K |
|
50
Novo Nordisk
NVO
$251B
| $677K | 0.28% |
12,600
+4,000
| +47% | +$215K |
|